128 related articles for article (PubMed ID: 8047696)
21. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
Kaulich K; Blaschke B; Nümann A; von Deimling A; Wiestler OD; Weber RG; Reifenberger G
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1092-9. PubMed ID: 12484572
[TBL] [Abstract][Full Text] [Related]
22. Genetics of astrocytic tumor progression.
Mikkelsen T
Mol Genet Med; 1993; 3():69-94. PubMed ID: 8220164
[No Abstract] [Full Text] [Related]
23. Oncogene transfer into the brain.
Wiestler OD; Brüstle O; Eibl RH; Radner H; Aguzzi A; Kleihues P
Recent Results Cancer Res; 1994; 135():55-66. PubMed ID: 8047697
[No Abstract] [Full Text] [Related]
24. Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways.
Zhang LH; Yang XL; Zhang X; Cheng JX; Zhang W
Brain Res; 2011 Jan; 1371():23-31. PubMed ID: 21112319
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
26. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.
Nilsson O; Wängberg B; Kölby L; Schultz GS; Ahlman H
Int J Cancer; 1995 Mar; 60(5):645-51. PubMed ID: 7860139
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of molecular alterations in microdissected archival gliomas.
Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
[TBL] [Abstract][Full Text] [Related]
28. Expression and functional roles of Smad1 and BMPR-IB in glioma development.
Liu S; Tian Z; Yin F; Zhang P; W Y; Ding X; Wu H; Wu Y; Peng X; Yuan J; Qiang B; Fan W; Fan M
Cancer Invest; 2009 Aug; 27(7):734-40. PubMed ID: 19513897
[TBL] [Abstract][Full Text] [Related]
29. The molecular biology and molecular genetics of astrocytic neoplasms.
Wong AJ; Zoltick PW; Moscatello DK
Semin Oncol; 1994 Apr; 21(2):139-48. PubMed ID: 8153660
[No Abstract] [Full Text] [Related]
30. Genomic instability and p53 alterations in patients with malignant glioma.
Milinkovic V; Bankovic J; Rakic M; Milosevic N; Stankovic T; Jokovic M; Milosevic Z; Skender-Gazibara M; Podolski-Renic A; Pesic M; Ruzdijic S; Tanic N
Exp Mol Pathol; 2012 Oct; 93(2):200-6. PubMed ID: 22664273
[TBL] [Abstract][Full Text] [Related]
31. Invasiveness in vitro and biological markers in human primary glioblastomas.
Laerum OD; Nygaar SJ; Steine S; Mørk SJ; Engebraaten O; Peraud A; Kleihues P; Ohgaki H
J Neurooncol; 2001 Aug; 54(1):1-8. PubMed ID: 11763417
[TBL] [Abstract][Full Text] [Related]
32. Analysis of epidermal growth factor receptor gene amplification and alteration in stereotactic biopsies of brain tumors.
Olson JJ; James CD; Krisht A; Barnett D; Hunter S
Neurosurgery; 1995 Apr; 36(4):740-6; discussion 747-8. PubMed ID: 7596505
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
Fults D; Pedone C
Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
[TBL] [Abstract][Full Text] [Related]
34. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry.
Koga H; Zhang S; Kumanishi T; Washiyama K; Ichikawa T; Tanaka R; Mukawa J
Acta Neuropathol; 1994; 87(3):225-32. PubMed ID: 8009954
[TBL] [Abstract][Full Text] [Related]
35. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB
J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770
[TBL] [Abstract][Full Text] [Related]
36. Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival.
Puduvalli VK; Kyritsis AP; Hess KR; Bondy ML; Fuller GN; Kouraklis GP; Levin VA; Bruner JM
Int J Oncol; 2000 Nov; 17(5):963-9. PubMed ID: 11029499
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutations of PTEN in glioblastoma multiforme.
Wang SI; Puc J; Li J; Bruce JN; Cairns P; Sidransky D; Parsons R
Cancer Res; 1997 Oct; 57(19):4183-6. PubMed ID: 9331071
[TBL] [Abstract][Full Text] [Related]
38. Expression of the neu oncogene under the transcriptional control of the myelin basic protein gene in transgenic mice: generation of transformed glial cells.
Hayes C; Kelly D; Murayama S; Komiyama A; Suzuki K; Popko B
J Neurosci Res; 1992 Jan; 31(1):175-87. PubMed ID: 1377283
[TBL] [Abstract][Full Text] [Related]
39. Astrocytic gliomas: characterization on a molecular genetic basis.
von Deimling A; Louis DN; Schramm J; Wiestler OD
Recent Results Cancer Res; 1994; 135():33-42. PubMed ID: 8047695
[No Abstract] [Full Text] [Related]
40. Timing of p53 mutations during astrocytoma tumorigenesis.
del Arco A; García J; Arribas C; Barrio R; Blázquez MG; Izquierdo JM; Izquierdo M
Hum Mol Genet; 1993 Oct; 2(10):1687-90. PubMed ID: 8268922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
